HFS
SNDX icon

Hughes Financial Services’s Syndax Pharmaceuticals SNDX Stock Holding History

Hughes Financial Services’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66 Buy
3
+1
+50% +$21 ﹤0.01% 1544
2026
Q1 		$47 Buy
+2
New +$43 ﹤0.01% 1465

Other funds holding SNDX

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

Hughes Financial Services's SNDX Position: Q2 2026 in Review

Hughes Financial Services increased its Syndax Pharmaceuticals (SNDX) stake by 50% in Q2 2026, buying an estimated $21 and bringing the position to 3 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #1544.

Hughes Financial Services first reported a position in SNDX in Q1 2026 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Hughes Financial Services held 3 shares of Syndax Pharmaceuticals worth $66 as of Q2 2026.
  • Hughes Financial Services bought 1 Syndax Pharmaceuticals share in Q2 2026, an estimated $21.
  • Syndax Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1544 holding.
  • Hughes Financial Services first reported a position in Syndax Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.